NO20005547L - Myelinbasisproteinpeptider og anvendelser derav - Google Patents
Myelinbasisproteinpeptider og anvendelser deravInfo
- Publication number
- NO20005547L NO20005547L NO20005547A NO20005547A NO20005547L NO 20005547 L NO20005547 L NO 20005547L NO 20005547 A NO20005547 A NO 20005547A NO 20005547 A NO20005547 A NO 20005547A NO 20005547 L NO20005547 L NO 20005547L
- Authority
- NO
- Norway
- Prior art keywords
- protein peptides
- base protein
- myelin base
- myelin
- peptides
- Prior art date
Links
- 102000006386 Myelin Proteins Human genes 0.000 title 1
- 108010083674 Myelin Proteins Proteins 0.000 title 1
- 210000005012 myelin Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7310998A | 1998-05-05 | 1998-05-05 | |
| PCT/US1999/009930 WO1999057241A2 (en) | 1998-05-05 | 1999-05-05 | Myelin basic protein peptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005547D0 NO20005547D0 (no) | 2000-11-03 |
| NO20005547L true NO20005547L (no) | 2001-01-02 |
Family
ID=22111789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005547A NO20005547L (no) | 1998-05-05 | 2000-11-03 | Myelinbasisproteinpeptider og anvendelser derav |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1080185A4 (no) |
| JP (1) | JP2002513558A (no) |
| CN (1) | CN1308671A (no) |
| AU (1) | AU3789099A (no) |
| CA (1) | CA2330826A1 (no) |
| HK (1) | HK1039636A1 (no) |
| NO (1) | NO20005547L (no) |
| NZ (1) | NZ507901A (no) |
| WO (1) | WO1999057241A2 (no) |
| ZA (1) | ZA200006268B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
| EP1487480B1 (en) * | 2001-05-01 | 2015-10-07 | The Regents of The University of California | Fusion molecules for treatment of immune diseases |
| ITFI20010114A1 (it) | 2001-06-22 | 2002-12-22 | Univ Firenze | Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla |
| CN101990545A (zh) * | 2007-11-20 | 2011-03-23 | 埃尔德鲁格股份有限公司 | 肽类似物及其结合物 |
| JPWO2016159181A1 (ja) * | 2015-03-30 | 2018-02-22 | 国立大学法人大阪大学 | 免疫用ペプチド、免疫用ペプチドの製造方法、それを含む免疫疾患用医薬組成物、および免疫疾患の治療方法 |
| EP4461303A3 (en) * | 2019-06-18 | 2025-05-14 | The Scripps Research Institute | Methods and compositions for treating inflammatory conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5734023A (en) * | 1991-11-19 | 1998-03-31 | Anergen Inc. | MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses |
| AU4278296A (en) * | 1994-10-25 | 1996-05-15 | Immulogic Pharmaceutical Corporation | Compositions and treatment for multiple sclerosis |
| EP0833930A2 (en) * | 1995-06-07 | 1998-04-08 | ZymoGenetics, Inc. | Fused soluble mhc heterodimer:peptide complexes and their uses |
-
1999
- 1999-05-05 EP EP99920379A patent/EP1080185A4/en not_active Withdrawn
- 1999-05-05 NZ NZ507901A patent/NZ507901A/xx unknown
- 1999-05-05 JP JP2000547197A patent/JP2002513558A/ja active Pending
- 1999-05-05 CA CA002330826A patent/CA2330826A1/en not_active Abandoned
- 1999-05-05 WO PCT/US1999/009930 patent/WO1999057241A2/en not_active Ceased
- 1999-05-05 CN CN99808248A patent/CN1308671A/zh active Pending
- 1999-05-05 HK HK02101092.3A patent/HK1039636A1/zh unknown
- 1999-05-05 AU AU37890/99A patent/AU3789099A/en not_active Abandoned
-
2000
- 2000-11-02 ZA ZA200006268A patent/ZA200006268B/en unknown
- 2000-11-03 NO NO20005547A patent/NO20005547L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1308671A (zh) | 2001-08-15 |
| WO1999057241A3 (en) | 2000-01-13 |
| NZ507901A (en) | 2003-06-30 |
| JP2002513558A (ja) | 2002-05-14 |
| WO1999057241A9 (en) | 2000-02-17 |
| WO1999057241A2 (en) | 1999-11-11 |
| EP1080185A4 (en) | 2005-01-26 |
| ZA200006268B (en) | 2001-08-22 |
| HK1039636A1 (zh) | 2002-05-03 |
| EP1080185A2 (en) | 2001-03-07 |
| CA2330826A1 (en) | 1999-11-11 |
| NO20005547D0 (no) | 2000-11-03 |
| AU3789099A (en) | 1999-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000700L (no) | Interleukin-18-proteiner samt fremstilling og anvendelse derav | |
| ITMI982280A0 (it) | Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono | |
| NO20040246L (no) | TACI'er- og BR3-polypeptider og anvendelser derav | |
| EP1461605A4 (en) | NANOSTERIALS OF PROTEINS AND PEPTIDES | |
| NO982097L (no) | Peptider | |
| NO982098L (no) | Peptider | |
| NO991150D0 (no) | Pyrazolopyrimidiner og pyrazolotriaziner | |
| IS4496A (is) | Úðablöndur úr peptíðum og próteinum | |
| NO20034962D0 (no) | Beta-amyloid peptid-bindende proteiner og polynukleotider som koder for samme | |
| DE69822917D1 (de) | Abtast- und Halteschaltung | |
| EP1056465A4 (en) | ANTIMICROBIAL PEPTIDES AND DERIVATIVE METAPEPTIDES | |
| NO20040880L (no) | Casein avledete peptider og anvendelser derav i terapi. | |
| DE69705017D1 (de) | Medikamente bindendes Protein | |
| NO20005547L (no) | Myelinbasisproteinpeptider og anvendelser derav | |
| NO995062D0 (no) | <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme | |
| GB9918155D0 (en) | Proteins and peptides | |
| ATE295417T1 (de) | Angiostatin-bindendes protein | |
| DE69816241D1 (de) | Aktivierte peptide und konjugate | |
| ATA1972000A (de) | Rekombinant hergestelltes menschliches intestinales npt2b-polypeptid | |
| IL153740A0 (en) | Grf2-binding proteins and applications thereof | |
| NO20012283D0 (no) | Koblede peptider | |
| NO20020794D0 (no) | Meg-1-protein | |
| EP1151100A4 (en) | TAU-CONOTOXIN PEPTIDE | |
| GB0102447D0 (en) | Protein variants and uses thereof | |
| DK0907370T3 (da) | HLA-A2.1-Bindingspeptider og deres anvendelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |